Phase 2 Pulmonary Arterial Hypertension trials recruiting now
All Pulmonary Arterial Hypertension trials, every phase
11
Phase 2 recruiting
Other phases for Pulmonary Arterial Hypertension
Phase 2 Pulmonary Arterial Hypertension trials
- 129 Xenon Imaging in Patients Treated With Sotatercept
- 129 Xenon MRI as a Biomarker for Diagnosis and Response to Therapy in Pulmonary Arterial Hypertension (PAH)
- A Study of HS235 for Treatment of Pulmonary Arterial Hypertension (PAH) in Adults
- A Study of Sotatercept (MK-7962) in Japanese Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-032)
- A Trial of "APL-9796'' in Adults With Pulmonary Hypertension
- DIAG723 in Adults With Hereditary Hemorrhagic Telangiectasia
- Pulmonary Hypertension SOLAR
- Repurposing Valsartan May Protect Against Pulmonary Hypertension
- Spironolactone for Pulmonary Arterial Hypertension
- Study to Evaluate Sotatercept (MK-7962) in Children With Pulmonary Arterial Hypertension (PAH) (MK-7962-008)
- Xenon MRI Pulm Hypertension
Common questions
What does Phase 2 mean?
Is this list complete?
No. For the full record, search ClinicalTrials.gov.